Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193125-26-053451·AMERIPRISE FINANCIAL INC
Schedule 13G ownership disclosure
PASITHEA THERAPEUTICS CORP
Common Stock · CUSIP: 70261F202
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ameriprise Financial, Inc.
Shares: 1,930,128 · Class: 8.4%
- Columbia Management Investment Advisers, LLC
Shares: 1,930,128 · Class: 8.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-053451
- Form type
- SCHEDULE 13G
- Filer
- AMERIPRISE FINANCIAL INC
- CIK
- CIK 820027
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership